(Reuters) - Drugmaker XenoPort Inc and its partner GlaxoSmithKline Plc said the U.S. health regulator approved their drug to treat shingles related nerve pain that may cause disability in some people. XenoPort will get a milestone payment of $10 m...
Source: http://health.yahoo.net/news/s/nm/glaxo-xenoport-s-drug-gets-fda-nod-for-new-use
UBS AG Netflix Scarlett Johansson Medal of Honor
No comments:
Post a Comment
Note: only a member of this blog may post a comment.